Suchergebnisse - "Tsuboi, Masahiro"

PubPharm (34)

1

Neoadjuvant nivolumab plus chemotherapy in resectable non-small-cell lung cancer in Japanese patients from CheckMate 816

enthalten in: Cancer science | 2024

von Mitsudomi, T. | Ito, H. | Okada, M. | +16

2

Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer with radiologically pure-solid appearance in Japan (JCOG0802/WJOG4607L) : a post-hoc supplemental analysis of a multicentre, open-label, phase 3 trial

enthalten in: The Lancet. Respiratory medicine | 2024

von Hattori, A. | Suzuki, K. | Takamochi, K. | +22

3

Five-Year Overall Survival Analysis of the JIPANG Study : Pemetrexed or Vinorelbine Plus Cisplatin for Resected Stage II-IIIA Nonsquamous Non-Small-Cell Lung Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Kenmotsu, H. | Yamamoto, N. | Misumi, T. | +17

4

Three-Year Safety, Tolerability, and Health-Related Quality of Life Outcomes of Adjuvant Osimertinib in Patients With Resected Stage IB to IIIA EGFR-Mutated NSCLC : Updated Analysis From the Phase 3 ADAURA Trial

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2023

von John, T. | Grohé, C. | Goldman, J. | +17

5

Quality of life with docetaxel plus cisplatin versus paclitaxel plus carboplatin in patients with completely resected non-small cell lung cancer : quality of life analysis of TORG 0503

enthalten in: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation | 2023

von Matsuda, A. | Yamaoka, K. | Kunitoh, H. | +6

6

Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer

enthalten in: The New England journal of medicine | 2023

von Wakelee, H. | Liberman, M. | Kato, T. | +117

CommentIn: Transl Lung Cancer Res. 2023 Nov 30;12(11):2359-2365. - PMID 38090512

7

Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC

enthalten in: The New England journal of medicine | 2023

von Tsuboi, M. | Herbst, R. | John, T. | +118

CommentIn: Nat Rev Clin Oncol. 2023 Aug;20(8):504. - PMID 37311902

8

Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non-Small-Cell Lung Cancer : Updated Results From the Phase III Randomized ADAURA Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Herbst, R. | Wu, Y. | John, T. | +22

ErratumIn: J Clin Oncol. 2023 Aug 1;41(22):3877. - PMID 37104731

9

Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB-IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091) : an interim analysis of a randomised, triple-blind, phase 3 trial

enthalten in: The Lancet. Oncology | 2022

von O'Brien, M. | Paz-Ares, L. | Marreaud, S. | +19

CommentIn: Lancet Oncol. 2022 Dec;23(12):e528. - PMID 36455577

10

Randomized phase II trial of pemetrexed-cisplatin plus bevacizumab or thoracic radiotherapy followed by surgery for stage IIIA (N2) nonsquamous non-small cell lung cancer

enthalten in: The Journal of thoracic and cardiovascular surgery | 2022

von Takamochi, K. | Suzuki, K. | Tsuboi, M. | +22

CommentIn: J Thorac Cardiovasc Surg. 2022 Sep;164(3):672-673. - PMID 35125212